Inventor · disambiguated record
Nina Finkelstein
Also filed as: FINKELSTEIN NINA
27 granted patents·23 pending applications·166 citations·filing 1995–2010
96Inventor score
Files withTEVA PHARMA27FINKELSTEIN NINA9TEVA PHARMACEUTICALS USA INC F3BRAUDE VIVIANA2MENDELOVICI MARIOARA1
Top patents by PatentIndex Score
50 records- 0189US7067669B2Substantially pure cilostazol and processes for making sameTEVA PHARMA·Filed 2005·Granted Jun 27, 2006·5 cites·8 claims
- 0288US7064208B2Substantially pure cilostazol and processes for making sameTEVA PHARMA·Filed 2005·Granted Jun 20, 2006·5 cites·9 claims
- 0388US6515128B2Processes for preparing cilostazolTEVA PHARMA·Filed 2001·Granted Feb 4, 2003·20 cites·11 claims
- 0486US7060833B2Substantially pure cilostazol and processing for making sameTEVA PHARMA·Filed 2004·Granted Jun 13, 2006·11 cites·16 claims
- 0586US6825214B2Substantially pure cilostazol and processes for making sameTEVA PHARMA·Filed 2003·Granted Nov 30, 2004·11 cites·8 claims
- 0685US7692010B2Reference standard for characterization of rosuvastatinTEVA PHARMA·Filed 2007·Granted Apr 6, 2010·2 cites·2 claims
- 0785US7692008B2Reference standard for characterization of rosuvastatinTEVA PHARMA·Filed 2007·Granted Apr 6, 2010·2 cites·2 claims
- 0885US7060837B2Method for the purification of lansoprazoleTEVA PHARMA·Filed 2005·Granted Jun 13, 2006·3 cites·16 claims
- 0984US7692009B2Reference standard for characterization of rosuvastatinTEVA PHARMA·Filed 2007·Granted Apr 6, 2010·2 cites·2 claims
- 1082US7022859B2Method for the purification of lansoprazoleTEVA PHARMA·Filed 2005·Granted Apr 4, 2006·2 cites·15 claims
- 1180US6696601B2Hydrate forms of alendronate sodium, processes for manufacture thereof, and pharmaceutical compositions thereofTEVA PHARMA·Filed 2001·Granted Feb 24, 2004·11 cites·37 claims
- 1276US6909004B2Method for the purification of lansoprazoleTEVA PHARMA·Filed 2003·Granted Jun 21, 2005·5 cites·1 claims
- 1375US6963008B2Hydrate forms of alendronate sodium, processes for manufacture thereof, and pharmaceutical compositions thereofTEVA PHARMA·Filed 2003·Granted Nov 8, 2005·8 cites·2 claims
- 1475US5646188APolyamine derivatives of 1-aminoindanTEVA PHARMA·Filed 1995·Granted Jul 8, 1997·46 cites·41 claims
- 1572US7915423B2Solid states of pantoprazole sodium, processes for preparing them and processes for preparing known pantoprazole sodium hydratesTEVA PHARMA·Filed 2007·Granted Mar 29, 2011·1 cites·7 claims
- 1671US7244844B2Reference standard for characterization of rosuvastatinTEVA PHARMA·Filed 2004·Granted Jul 17, 2007·2 cites·4 claims
- 1770US6545149B2Synthesis and crystallization of piperazine ring-containing compoundsTEVA PHARMA·Filed 2001·Granted Apr 8, 2003·3 cites·24 claims
- 1869US8148576B2Solid state forms of aliskiren compoundsFINKELSTEIN NINA·Filed 2010·Granted Apr 3, 2012·1 cites·7 claims
- 1968US7507829B2Solid states of pantoprazole sodium, processes for preparing them and processes for preparing known pantoprazole sodium hydratesTEVA PHARMA·Filed 2003·Granted Mar 24, 2009·3 cites·73 claims
- 2068US6576764B2Synthesis and crystallization of piperazine ring-containing compoundsTEVA PHARMA·Filed 2002·Granted Jun 10, 2003·2 cites·5 claims
- 2168US2008300409A1Crystalline clopidogrel hydrobromide and processes for preparation thereofTEVA PHARMACEUTICALS USA INC F·Filed 2008·Application pending·0 cites
- 2268US2008306268A1Crystalline clopidogrel hydrobromide and processes for preparation thereofTEVA PHARMACEUTICALS USA INC F·Filed 2008·Application pending·0 cites
- 2367US6777554B2Preparation of N-methylparoxetine and related intermediate compoundsTEVA PHARMA·Filed 2002·Granted Aug 17, 2004·3 cites·33 claims
- 2466US8487097B2Reference standard for characterization of rosuvastatinFINKELSTEIN NINA·Filed 2009·Granted Jul 16, 2013·0 cites·22 claims
- 2566US6281381B1Hydrate forms of alendronate sodium, processes for manufacture thereof, and pharmaceutical compositions thereofTEVA PHARMA·Filed 1999·Granted Aug 28, 2001·18 cites·22 claims
- 2666US2010029943A1Methods for preparing eszopiclone crystalline form a, substantially pure eszopiclone and optically enriched eszopicloneTEVA PHARMA·Filed 2009·Application pending·0 cites
- 2765US7741482B2Reference standard for characterization of rosuvastatinTEVA PHARMA·Filed 2007·Granted Jun 22, 2010·0 cites·5 claims
- 2863US2009187022A1Crystalline clopidogrel hydrobromide and processes for preparation thereofTEVA PHARMACEUTICALS USA INC F·Filed 2008·Application pending·0 cites
- 2961US2010000302A1Process for preparing forms of atorvastatin calcium substantially free of impuritiesTEVA PHARMA·Filed 2009·Application pending·0 cites
- 3059US7622588B2Method for the purification of lansoprazoleTEVA PHARMA·Filed 2005·Granted Nov 24, 2009·0 cites·3 claims
- 3159US2007270590A1Methods for preparing eszopiclone crystalline form a, substantially pure eszopiclone and optically enriched eszopicloneMENDELOVICI MARIOARA·Filed 2007·Application pending·0 cites
- 3258US7674923B2Process for preparing forms of atorvastatin calcium substantially free of impuritiesTEVA PHARMA·Filed 2005·Granted Mar 9, 2010·0 cites·1 claims
- 3357US2008004319A1Process for preparing 2-[(pyridinyl)methyl]sulfinyl-substituted benzimidazoles and novel chlorinated derivatives of pantoprazoleBRAUDE VIVIANA·Filed 2007·Application pending·0 cites
- 3456US7683177B2Process for preparing 2-[(pyridinyl)methyl]sulfinyl-substituted benzimidazoles and novel chlorinated derivatives of pantoprazoleTEVA PHARMA·Filed 2004·Granted Mar 23, 2010·0 cites·8 claims
- 3553US2006154957A1Crystalline clopidogrel hydrobromide and processes for preparation thereofFINKELSTEIN NINA·Filed 2005·Application pending·0 cites
- 3650US2004176591A1Novel synthesis and crystallization of peperazine ring-containing compoundsFiled 2004·Application pending·0 cites
- 3750US2003120068A1Novel synthesis and crystallization of piperazine ring-containing compoundsFiled 2003·Application pending·0 cites
- 3849US2003135043A1Novel synthesis and crystallization of piperazine ring-containing compoundsFiled 2003·Application pending·0 cites
- 3949US2009018336A1Racemization process of R-zopicloneFINKELSTEIN NINA·Filed 2008·Application pending·0 cites
- 4049US2010041885A1Crystalline forms of sitagliptin phosphatePERLMAN NURIT·Filed 2009·Application pending·0 cites
- 4146US2007197529A1Isolated desfluoro-linezolid, preparation thereof and its use as a reference marker and standardBRAUDE VIVIANA·Filed 2006·Application pending·0 cites
- 4245US2010029774A1Aliskiren monofumarate and processes for preparation thereofFINKELSTEIN NINA·Filed 2009·Application pending·0 cites
- 4345US2012095264A1Solid states of aliskiren free baseFINKELSTEIN NINA·Filed 2009·Application pending·0 cites
- 4444US2012029083A1Polymorphic forms of aliskiren hemifumarate and process for preparation thereofFINKELSTEIN NINA·Filed 2008·Application pending·0 cites
- 4544US2004235904A1Crystalline and amorphous solids of pantoprazole and processes for their preparationFiled 2004·Application pending·0 cites
- 4644US2007167382A1Crystalline and amorphous forms of telithromycinFINKELSTEIN NINA·Filed 2006·Application pending·0 cites
- 4743US2008287447A1Methods for preparing eszopicloneFINKELSTEIN NINA·Filed 2008·Application pending·0 cites
- 4842US2004138466A1Processes for the production of substituted 2-(2-pyridylmethyl) sulfinyl-1H-benzimidazolesFiled 2003·Application pending·0 cites
- 4942US2004010151A1Lansoprazole polymorphs and processes for preparation thereofFiled 2003·Application pending·0 cites
- 5040US2003069417A1Novel synthesis and crystallization of piperazine ring-containing compoundsFiled 2002·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Nina Finkelstein files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →